Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria

Chronic urticaria (CU) is a debilitating skin disease affecting around 1% of the population. CU can be subdivided into chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU). Different pathophysiological mechanisms have been proposed to play a role in the development of CU, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Nadja Højgaard, Sørensen, Jennifer Astrup, Ghazanfar, Misbah Noshela, Zhang, Ditte Georgina, Vestergaard, Christian, Thomsen, Simon Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379579/
https://www.ncbi.nlm.nih.gov/pubmed/37511088
http://dx.doi.org/10.3390/ijms241411328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379579/
https://www.ncbi.nlm.nih.gov/pubmed/37511088
http://dx.doi.org/10.3390/ijms241411328

Ejemplares similares